FDA Authorizes First Direct-To-Consumer Genetic Tests for Medical Conditions

FDA Authorizes First Direct-To-Consumer Genetic Tests for Medical Conditions

The U.S. Food and Drug Administration Thursday authorized the first direct-to-consumer genetic tests for one’s predisposition to medical diseases and conditions. The FDA gave the green light for marketing of 23andMe Personal Genome Service Genetic Health Risk tests for 10 specific diseases or conditions. [4/6/17]

Search